Development and optimization of micro/nanoporous osmotic pump tablets

Micro/nanoporous osmotic pump tablets coated with cellulose acetate containing polyvinylpyrolidone (PVP) as pore formers were fabricated. Propranolol hydrochloride was used as a model drug in this study. Formulation optimization based on USP 31 requirements was conducted following a central composit...

Full description

Saved in:
Bibliographic Details
Main Authors: Siracha Tuntikulwattana, Ampol Mitrevej, Teerakiat Kerdcharoen, Desmond B. Williams, Nuttanan Sinchaipanid
Other Authors: Mahidol University
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/28496
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.28496
record_format dspace
spelling th-mahidol.284962018-09-24T16:41:43Z Development and optimization of micro/nanoporous osmotic pump tablets Siracha Tuntikulwattana Ampol Mitrevej Teerakiat Kerdcharoen Desmond B. Williams Nuttanan Sinchaipanid Mahidol University University of South Australia Agricultural and Biological Sciences Pharmacology, Toxicology and Pharmaceutics Micro/nanoporous osmotic pump tablets coated with cellulose acetate containing polyvinylpyrolidone (PVP) as pore formers were fabricated. Propranolol hydrochloride was used as a model drug in this study. Formulation optimization based on USP 31 requirements was conducted following a central composite design using a two-level factorial plan involving two membrane variables (pore former and coating levels). Effect of molecular weight of pore former (PVP K30 and PVP K90) was also evaluated. Responses of drug release to the variables were analyzed using statistical software (MINITAB 14). Scanning electron microscopy and atomic force microscopy showed that the pores formed by PVP. The drug release was dependent on the molecular weight and concentration of PVP and the level of coating. The results showed that acceptable 12-h profile could be achieved with only specific range of PVP K30-containing membrane at the defined membrane thickness. However, satisfactory 24-h profile could be accomplished by both PVP K30 and PVP K90-containing membrane at the range and membrane thickness tested. Preparation and testing of the optimized formulation showed a good correlation between predicted and observed values. © 2010 American Association of Pharmaceutical Scientists. 2018-09-24T08:38:40Z 2018-09-24T08:38:40Z 2010-06-01 Article AAPS PharmSciTech. Vol.11, No.2 (2010), 924-935 10.1208/s12249-010-9446-4 15309932 2-s2.0-77954818612 https://repository.li.mahidol.ac.th/handle/123456789/28496 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77954818612&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Agricultural and Biological Sciences
Pharmacology, Toxicology and Pharmaceutics
spellingShingle Agricultural and Biological Sciences
Pharmacology, Toxicology and Pharmaceutics
Siracha Tuntikulwattana
Ampol Mitrevej
Teerakiat Kerdcharoen
Desmond B. Williams
Nuttanan Sinchaipanid
Development and optimization of micro/nanoporous osmotic pump tablets
description Micro/nanoporous osmotic pump tablets coated with cellulose acetate containing polyvinylpyrolidone (PVP) as pore formers were fabricated. Propranolol hydrochloride was used as a model drug in this study. Formulation optimization based on USP 31 requirements was conducted following a central composite design using a two-level factorial plan involving two membrane variables (pore former and coating levels). Effect of molecular weight of pore former (PVP K30 and PVP K90) was also evaluated. Responses of drug release to the variables were analyzed using statistical software (MINITAB 14). Scanning electron microscopy and atomic force microscopy showed that the pores formed by PVP. The drug release was dependent on the molecular weight and concentration of PVP and the level of coating. The results showed that acceptable 12-h profile could be achieved with only specific range of PVP K30-containing membrane at the defined membrane thickness. However, satisfactory 24-h profile could be accomplished by both PVP K30 and PVP K90-containing membrane at the range and membrane thickness tested. Preparation and testing of the optimized formulation showed a good correlation between predicted and observed values. © 2010 American Association of Pharmaceutical Scientists.
author2 Mahidol University
author_facet Mahidol University
Siracha Tuntikulwattana
Ampol Mitrevej
Teerakiat Kerdcharoen
Desmond B. Williams
Nuttanan Sinchaipanid
format Article
author Siracha Tuntikulwattana
Ampol Mitrevej
Teerakiat Kerdcharoen
Desmond B. Williams
Nuttanan Sinchaipanid
author_sort Siracha Tuntikulwattana
title Development and optimization of micro/nanoporous osmotic pump tablets
title_short Development and optimization of micro/nanoporous osmotic pump tablets
title_full Development and optimization of micro/nanoporous osmotic pump tablets
title_fullStr Development and optimization of micro/nanoporous osmotic pump tablets
title_full_unstemmed Development and optimization of micro/nanoporous osmotic pump tablets
title_sort development and optimization of micro/nanoporous osmotic pump tablets
publishDate 2018
url https://repository.li.mahidol.ac.th/handle/123456789/28496
_version_ 1763493421133070336